Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Index analysis

Nifty Healthcare Index

Track price history, valuation, seasonal returns and the companies driving this index.

Latest level17167.70
1 day-0.38%
1 month+9.46%
YTD+17.49%
P/E · 16 Nov 202646.37

About

The Nifty Healthcare index tracks a broader healthcare universe than Nifty Pharma. Besides drug makers it includes hospital chains, diagnostic laboratories and other healthcare service providers. It holds up to 20 stocks weighted by free-float market capitalisation; the history on this page starts in November 2020.

Pharma companies make up a large part of the index, so it is driven by the same factors as Nifty Pharma: US generics pricing and approvals, domestic demand and regulatory inspections. The hospital and diagnostics businesses add exposure to domestic healthcare spending, bed capacity and occupancy.

Performance

Historical price

Valuation

P/E history

As of 13 November 2026, the Nifty Healthcare index trades at a trailing P/E of 46.4, against a five-year median of 37.6 (range 30.6 to 47.0). The chart plots the P/E that NSE publishes for the index, based on the reported earnings of its constituents.

Seasonality

Monthly returns

The grid shows the index's price return in each calendar month, with the median, average and standard deviation for each month at the bottom. Of the 72 months from December 2020 to November 2026 (month to date), 43 closed higher.

On average July has been the strongest month (+5.21%) and January the weakest (-3.52%). Monthly averages are based on a limited number of years and can be dominated by one or two unusual months.

YearJanFebMarAprMayJunJulAugSepOctNovDecYear

Long term

Year-on-year returns

The year-on-year chart shows calendar-year price returns, excluding dividends. Over the last five full years: 2021: +18.3%, 2022: -10.8%, 2023: +32.9%, 2024: +40.6%, 2025: -2.1%. So far in 2026, to 13 November, the index has returned +17.7%.

Since 2021, the best calendar year was 2024 (+40.6%) and the weakest 2022 (-10.8%). Past yearly returns describe how the sector has behaved; they do not indicate future returns.

Composition

Constituents (20)

The table lists the 20 stocks in the index with each one's sector, latest price, return, one-month return and market capitalisation. By market capitalisation the largest constituents are SUNPHARMA, DIVISLAB, CIPLA, TORNTPHARM and ZYDUSLIFE.

NSE reviews the constituents of its sectoral indices twice a year, so the list changes over time.

SymbolSectorReturnPrice1M returnMarket cap